Puya Supply Abarelix CAS 183552-38-7 Use For Prostate Cancer

Puya Supply Abarelix CAS 183552-38-7 Use For Prostate Cancer

Product Name: Abarelix
Synonyms: PPI-149;Abarelix Acetate;Plenaxis;R 3827;Ac-DNal-DCpa-DPal-Ser-NαMeTyr-DAsp-Leu-Ilys-Pro-DAl-NH2;Abarelix;Abarelix Acetate(Plenaxis);D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
CAS: 183552-38-7
MF: C72H95ClN14O14
MW: 1416.06
EINECS: 1592732-453-0
Product Categories:
Mol File: 183552-38-7.mol

Abarelix reduces testosterone production in the testes by directly inhibiting the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH). Because of the direct inhibition of LH secretion by Chemicalbook, plasma testosterone concentration does not increase and then decrease. The results of the study showed that abarelix acetate has a high affinity for the pituitary LHRH receptors in rats.

Abarelix CAS 183552-38-7 Chemical Properties
Abarelix Chemical Properties
Boiling point 1688.4±65.0 °C(Predicted)
density 1.286±0.06 g/cm3(Predicted)
pka 9.82±0.15(Predicted)
CAS DataBase Reference 183552-38-7

Function and Application of Abarelix CAS 183552-38-7
Abarelix, an antineoplastic agent, is the 1st storable gonadotropin-releasing hormone antagonist formulation currently approved and the 1st new type of prostate cancer drug.

Abarelix CAS 183552-38-7 Use For Prostate Cancer